gener
believ
influenza
outbreak
associ
breathborn
transmiss
virus
howev
relev
evid
littl
respiratori
bacteri
infect
anoth
front
pointofcar
infect
diagnost
method
bedsid
significantli
lack
use
newli
develop
protocol
integr
exhal
breath
condens
ebc
collect
devic
pku
bioscreen
loop
mediat
isotherm
amplif
lamp
investig
bacteri
pathogen
directli
exhal
human
exhal
breath
condens
collect
human
subject
respiratori
infect
symptom
peke
univers
hospit
use
bioscreen
screen
bacteri
pathogen
includ
streptococcu
pneumonia
staphylococcu
aureu
methicillinresist
stphylococcu
aureu
mrsa
escherichia
coli
klebsiella
pneumonia
pseudomona
aeruginosa
acinetobact
baumannii
stenotrophomona
maltophilia
haemophilu
influenza
legionella
pneumophila
mycoplasma
pneumonia
chlamydia
pneumonia
mycobacterium
tuberculosi
result
compar
valid
use
throat
swab
patient
pcr
method
human
bacteri
pathogen
h
influenza
p
aeruginosa
e
coli
aureu
mrsa
detect
exhal
breath
use
develop
protocol
integr
ebc
collect
lamp
patient
recruit
hospit
seven
type
pathogen
detect
remain
subject
none
screen
bacteri
pathogen
detect
importantli
super
resist
bacteria
mrsa
detect
exhal
breath
suggest
breath
might
also
import
bacteri
transmiss
rout
result
throat
swab
show
subject
found
infect
h
influenza
p
aeruginosa
e
coli
maltophilia
aureu
mrsa
ebc
sampl
found
infect
mrsa
e
coli
p
aeruginosa
depend
initi
pathogen
load
sampl
entir
protocol
ebclamp
take
min
complet
respiratori
infect
diagnosi
differ
detect
method
pathogen
agreement
ebc
throat
swab
patient
found
rang
detect
sever
bacteri
pathogen
includ
mrsa
exhal
breath
develop
protocol
could
use
bedsid
pathogen
screen
particularli
remot
area
resourc
significantli
limit
prohibit
exhal
breath
condens
sampl
collect
use
exhal
breath
collect
devic
pku
bioscreen
develop
laboratori
similar
procedur
devic
use
describ
previou
studi
subject
id
ask
continu
exhal
normal
breath
rate
five
minut
toward
devic
cm
away
subject
exhal
breath
quickli
form
tini
droplet
hydrophob
surfac
top
cool
unit
collect
droplet
ml
centrifug
tube
analysi
drag
di
water
droplet
film
collect
devic
somehow
work
like
impactor
posit
airflow
vacuum
also
larg
collect
surfac
compar
straw
impactor
jet
therefor
collect
effici
high
given
larg
pathogen
contain
exhal
droplet
standard
impactor
equat
use
calcul
previou
studi
collect
detect
influenza
virus
use
devic
accordingli
devic
could
small
least
abl
collect
breathborn
virus
even
differ
subject
differ
exhal
veloc
wo
nt
affect
perform
much
typic
obtain
ebc
within
min
collect
subject
involv
work
detect
pathogen
intend
qualit
analysi
thu
absolut
physic
collect
effici
pathogen
play
minor
role
data
analysi
nonetheless
certainli
interest
character
physic
collect
effici
ebc
collect
devic
work
use
devic
without
cool
step
amount
ebc
collect
limit
compar
cool
typic
one
cool
unit
last
subject
ebc
collect
without
substanti
lose
much
ebc
collect
effici
throat
swab
collect
use
common
bacteria
collect
tube
youkang
biotechnolog
beij
co
ltd
item
wipe
retropharyng
wall
patient
id
use
steril
swab
transfer
swab
buffer
quickli
pathogen
extract
buffer
solut
vigor
vortex
min
vortex
rate
rpm
vortex
scientif
industri
co
ltd
ml
extract
solut
transfer
ml
centrifug
tube
detect
subject
also
collect
clinic
data
includ
gender
age
health
condit
blood
routin
examin
result
maximum
bodi
temperatur
tabl
qualiti
control
also
use
high
volum
sampler
take
hospit
room
air
subject
lamp
method
analysi
addit
blank
di
water
neg
ebc
devic
util
onetim
use
hydrophob
film
prevent
crosscontamin
patient
elimin
possibl
upgrad
version
bioscreen
equip
intern
separ
sit
collect
wall
devic
exhal
breath
mouth
separ
also
onetim
consum
chang
everi
patient
howev
use
first
version
devic
report
xu
et
al
human
sampl
collect
approv
institut
review
board
peke
univers
pu
irb
approv
inform
consent
form
attain
patient
prior
experi
describ
total
nucleic
acid
extract
whole
ebc
sampl
ml
ml
throat
swab
sampl
firstli
centrifug
sampl
rpm
min
centrifug
r
eppendorf
total
dna
extract
specimen
bacteria
dna
extract
kit
tianamp
bacteria
dna
kit
tiangen
biotech
beij
co
ltd
describ
manufactur
instruct
dna
extract
kit
util
silica
membran
technolog
special
buffer
system
lysozym
wide
rang
gramneg
gramposit
bacteria
tiangen
beij
dna
elut
te
buffer
suppli
kit
studi
aim
test
four
type
bacteria
pathogen
includ
haemophilu
influenza
pseudomona
aerugino
staphylococcu
aureu
methicillinresist
stphylococcu
aureu
mrsa
one
viru
type
influenza
use
protocol
primer
use
lamp
detect
pathogen
list
tabl
refer
describ
use
previou
studi
primer
use
work
synthes
sangon
biotech
shanghai
co
ltd
bacteria
detect
lamp
assay
carri
ul
reaction
mixtur
contain
templat
dna
fip
bip
lf
lb
design
bst
dna
polymeras
larg
fragment
rm
mm
dntp
mixtur
mm
mgso
mm
kcl
mm
nh
tween
betain
eiken
chemic
co
ltd
tochigi
japan
remain
ddh
ad
mixtur
incub
min
h
influenza
p
aeruginosa
mrsa
aureu
heat
min
termin
reaction
loopamp
realtim
turbidimet
kyoto
japan
detect
influenza
viru
use
onestep
revers
transcriptionloop
mediat
isotherm
amplif
rtlamp
assay
rapid
detect
ptlamp
reaction
perform
loopamp
rna
amplif
kit
eiken
chemic
co
ltd
tokyo
japan
reaction
mixtur
contain
primer
fip
bip
outer
primer
reaction
mix
amplif
mixtur
contain
bst
dna
polymeras
avian
myeloblastosi
viru
revers
transcriptas
rna
sampl
incub
min
heat
min
termin
reaction
use
realtim
turbidimet
kyoto
japan
realtim
amplif
lamp
assay
monitor
spectrophotometr
analysi
record
optic
densiti
nm
everi
help
loopamp
realtim
turbidimet
kyoto
japan
sampl
treat
posit
specif
pathogen
turbid
valu
exce
set
threshold
eg
certain
time
tt
minut
posit
neg
control
includ
run
necessari
step
perform
prevent
possibl
crosscontamin
pcr
amplif
reaction
primer
probe
use
amplifi
gene
h
influenza
coa
gene
aureu
cell
ecfx
gene
p
aeruginosa
cell
list
tabl
accord
previou
publish
studi
synthes
work
sangon
biotech
shanghai
co
ltd
h
influenza
pcr
assay
carri
volum
contain
dna
templat
nm
primer
dntp
u
taq
polymeras
taq
buffer
remain
ddh
ad
pcr
amplif
perform
use
follow
cycl
paramet
denatur
min
follow
cycl
min
final
elong
step
min
pcr
product
visual
electrophoresi
use
agaros
gel
stain
ethidium
bromid
p
aeruginosa
pcr
reaction
mixtur
total
volum
includ
dna
templat
primer
dntp
u
taq
polymeras
taq
buffer
remain
ddh
ad
pcr
amplif
perform
biorad
thermal
cycler
biorad
usa
initi
denatur
step
min
cycl
final
elong
step
min
pcr
product
visual
electrophoresi
use
agaros
gel
stain
ethidium
bromid
aureu
pcr
amplif
carri
final
reaction
volum
mixtur
consist
dna
templat
primer
dntp
u
taq
polymeras
taq
buffer
remain
ddh
ad
amplif
perform
biorad
thermal
cycler
biorad
usa
pcr
cycl
consist
preheat
denatur
anneal
extens
amplif
perform
cycl
final
extens
step
min
pcr
product
visual
electrophoresi
use
agaros
gel
contain
mg
ethidium
bromid
per
millilit
studi
also
screen
common
respiratori
pathogen
clinic
sampl
shown
tabl
investig
major
pathogen
respons
respiratori
infect
use
commerci
multipledetect
chip
detect
system
rtisochiptma
capitalbio
tech
co
ltd
beij
clinic
sampl
pathogen
detect
pathogen
combin
lamp
method
microfluid
techniqu
purifi
sampl
analysi
simultan
screen
differ
pathogen
singl
run
name
pathogen
list
tabl
screen
conduct
ebc
sampl
id
throat
swab
id
list
tabl
experiment
data
analyz
use
statist
packag
corpor
compar
lamp
pcr
result
conduct
kappa
test
mcnemar
test
guidelin
character
kappa
valu
excel
fair
good
poor
comparison
made
group
differ
analysi
techniqu
pcr
lamp
respect
ebc
throat
swab
collect
subject
work
select
pathogen
found
detect
limit
air
sampl
collect
hospit
room
ebc
throat
swab
collect
work
pvalu
indic
statist
signific
differ
work
recruit
total
patient
flu
symptom
novemb
may
inform
shown
tabl
among
throat
swab
collect
patient
id
id
ask
collect
ebc
sampl
use
pku
bioscreen
ebc
volum
patient
adequ
lamp
analysi
overal
shown
certain
bacteri
pathogen
exhal
develop
pathogen
screen
protocol
integr
ebc
lamp
use
one
noninvas
rapid
respiratori
pathogen
screen
method
work
total
screen
ebc
specimen
id
throat
swab
id
collect
recruit
patient
list
tabl
detect
common
bacteri
pathogen
h
influenza
use
qpcr
lamp
pku
bioscreen
shown
abl
collect
ebc
within
min
patient
id
h
influenza
detect
six
sampl
id
ebc
sampl
id
four
correspond
throat
swab
specimen
id
found
posit
bacteria
shown
fig
remain
result
ie
detect
time
list
tabl
support
info
shown
tabl
patient
id
use
lamp
detect
h
influenza
agreement
neg
posit
ebc
throat
sampl
collect
patient
evalu
perform
lamp
method
sampl
also
analyz
use
qpcr
assay
detect
h
influenza
shown
tabl
agreement
qpcr
method
use
two
differ
sampl
howev
advantag
ebclamp
protocol
use
ebc
might
need
sampl
pretreat
seen
fig
interest
thing
influenzaeposit
ebc
sampl
threshold
time
tt
valu
use
lamp
method
shorter
correspond
throat
swab
subject
find
impli
ebc
could
somehow
serv
better
sampl
lamp
analysi
bacteri
pathogen
term
detect
time
possibl
result
dilut
medium
less
complex
throat
swab
exampl
took
min
ebc
sampl
patient
highest
concentr
save
min
compar
use
correspond
throat
swab
subject
tabl
list
common
respiratori
pathogen
involv
multipledetect
chip
name
pathogen
abbrevi
index
tabl
howev
also
sever
throat
swab
sampl
id
detect
posit
h
influenza
none
detect
correspond
ebc
subject
shown
tabl
possibl
reason
could
due
lower
concentr
level
pathogen
ebc
sampl
compar
throat
swab
subject
could
aris
variat
pathogen
concentr
ebc
collect
process
among
differ
patient
patient
infect
h
influenza
proport
neutrophil
granulocyt
rang
list
tabl
thu
difficult
make
decis
base
empir
threshold
rule
neutrophil
granulocyt
mix
impact
variou
factor
clinic
present
respiratori
infect
rather
difficult
imposs
reliabl
predict
pathogen
base
clinic
sign
symptom
caliendo
nonetheless
compar
perform
ebc
throat
swab
detect
pathogen
still
need
sampl
simpl
noninvas
method
ebc
increasingli
util
earli
diagnosi
diseas
eg
lung
cancer
asthma
influenza
respiratori
infect
papaioann
et
al
teng
et
al
ebc
demonstr
great
potenti
advantag
diseas
screen
diagnosi
combin
gold
standard
method
qpcr
elisa
method
ahmadzai
et
al
howev
addit
falseneg
low
level
pathogen
qpcr
method
take
longer
time
could
sever
hour
detect
falsey
et
al
hand
lamp
method
detect
variou
pathogen
attract
great
attent
recent
owe
higher
sensit
lower
detect
limit
compar
commonli
use
clinic
specimen
nasal
swab
bronchoalveolar
lavag
nasopharyng
aspir
sputum
exhal
breath
sampl
easili
collect
accordingli
use
ebc
sampl
togeth
lamp
rel
inexpens
solut
could
appli
rapid
pathogen
screen
overal
result
fig
tabl
show
bacteri
pathogen
h
influenza
emit
environ
via
human
breath
ebc
sampl
use
screen
pathogen
use
lamp
qpcr
reason
detect
rate
work
also
design
detect
three
type
bacteria
one
viru
type
use
lamp
protocol
support
file
show
detect
result
p
aeruginosa
mrsa
influenza
viru
detect
p
aeruginosa
throat
sampl
patient
result
ebclamp
qpcr
method
shown
file
agre
rate
includ
posit
case
id
detect
mrsa
ebc
sampl
result
lamp
qpcr
agre
includ
posit
case
id
high
agreement
partial
due
nonpres
mrsa
ebc
sampl
collect
detect
flua
throat
swab
four
posit
case
id
detect
main
object
work
evalu
perform
ebclamp
ebcqpcr
protocol
qualit
analysi
bacteri
pathogen
differ
sampl
detect
limit
howev
anoth
work
fulli
evalu
detect
limit
qpcr
lamp
method
control
condit
select
pathogen
includ
test
work
overal
found
lamp
method
tend
lower
detect
limit
qpcr
method
valid
ebclamp
protocol
ebc
throat
swab
sampl
test
commerci
lamp
detect
unit
rtisochiptma
capitalbio
tech
co
ltd
beij
shown
tabl
unit
abl
simultan
screen
thirteen
kind
pathogen
given
sampl
total
throat
swab
ebc
specimen
detail
medic
inform
correspond
patient
shown
tabl
screen
use
devic
shown
tabl
tabl
fig
exhal
breath
condens
sampl
four
detect
posit
e
coli
one
p
aeruginosa
one
mrsa
respect
one
subject
mrsa
e
coli
detect
ebc
addit
throat
swab
specimen
test
posit
least
one
type
bacteri
pathogen
includ
specimen
two
three
type
pathogen
among
h
influenza
show
obvious
higher
posit
rate
pathogen
suggest
h
influenza
domin
bacteria
respons
upper
respiratori
tract
infect
addit
h
influenza
p
aeruginosa
e
coli
maltophilia
aureu
mrsa
also
detect
ebc
throat
swab
sampl
patient
ebc
throat
sampl
collect
agreement
use
commerci
lamp
method
shown
fig
screen
pathogen
use
commerci
lamp
devic
show
differ
result
ebc
specimen
throat
swab
list
tabl
similar
result
ebclamp
protocol
develop
work
h
influenza
detect
domin
pathogen
posit
rate
commerci
unit
none
ebc
sampl
id
singl
pathogen
one
type
pathogen
detect
one
sampl
b
multipl
pathogen
one
type
pathogen
detect
one
sampl
fig
bacteri
pathogen
detect
ebc
throat
swab
sampl
use
commerci
lamp
devic
symbol
bar
shown
posit
rate
respect
pathogen
type
shown
xaxi
calcul
ratio
posit
number
type
pathogen
number
total
posit
rate
bacteria
percentag
also
figur
indic
frequenc
select
six
pathogen
detect
throat
swab
ebc
sampl
shown
tabl
found
posit
result
h
influenza
discuss
h
influenza
detect
ebc
sampl
use
ebclamp
protocol
develop
work
one
possibl
reason
pathogen
level
appear
lower
ebc
sampl
throat
swab
thu
commerci
devic
use
might
abl
detect
due
detect
limit
besid
commerci
lamp
devic
without
disclos
primer
inform
might
use
differ
primer
set
use
list
tabl
ebclamp
protocol
note
also
detect
mrsa
ebc
throat
swab
sampl
use
commerci
devic
time
mrsa
also
detect
use
ebclamp
assay
develop
aureu
especi
methicillinresist
aureu
mrsa
one
studi
pathogen
communityacquir
hospitalacquir
infect
associ
high
mortal
caus
great
concern
misawa
et
al
previou
studi
evalu
airborn
cultur
mrsa
chines
public
build
demonstr
mrsa
could
transmit
ambient
air
li
et
al
nonetheless
result
commerci
devic
show
differ
type
bacteri
pathogen
pae
e
coli
mrsa
exhal
studi
analyz
white
blood
cell
wbc
neutrophil
level
patient
found
infect
bacteri
pathogen
use
ebclamp
also
commerci
lamp
devic
result
shown
fig
patient
group
togeth
either
infect
singl
bacteri
pathogen
group
pathogen
h
influenza
p
aeruginosa
e
coli
aureu
maltophilia
mrsa
clinic
doctor
often
reli
empir
diagnosi
normal
refer
rang
white
blood
cell
wbc
percentag
neutrophil
cellsl
respect
seen
fig
patient
infect
bacteri
pathogen
except
one
patient
infect
e
coli
averag
wbc
level
appear
normal
refer
rang
even
lead
pathogen
h
influenza
patient
normal
wbc
level
howev
clinic
set
eg
respiratori
clinic
patient
gener
treat
viral
infect
normal
wbc
level
mean
lot
flu
patient
could
mistreat
hospit
wbcinfectiontyp
rule
discuss
use
hand
seem
averag
neutrophil
valu
appear
slightli
higher
normal
expect
eg
infect
lead
pathogen
h
influenza
p
aeruginosa
e
coli
maltophilia
also
combin
e
coli
h
influenza
result
fig
indic
empir
experi
eg
use
wbc
diagnosi
infect
type
ie
higher
bacteri
infect
could
lead
wrong
decis
respect
diagnosi
treatment
nonetheless
work
intend
evalu
protocol
effici
term
rapidli
screen
respiratori
pathogen
pathogen
infect
mechan
work
develop
valid
new
pathogen
detect
protocol
ebclamp
protocol
integr
ebc
lamp
method
use
protocol
shown
certain
bacteri
pathogen
h
influenza
p
aeruginosa
e
coli
aureu
maltophilia
mrsa
exhal
infect
patient
use
ebc
devic
abl
obtain
ebc
sampl
within
min
adequ
lamp
analysi
devic
adopt
onetim
use
hydrophob
film
also
intern
exhal
separ
upgrad
version
devic
prevent
crosscontamin
among
patient
ebc
collect
process
bioscreen
method
develop
laboratori
hold
promis
extend
ebc
sampl
analysi
diseas
diagnosi
mani
differ
field
sinc
portabl
fast
without
extern
use
power
littl
cross
contamin
contrast
current
avail
devic
found
h
influenza
lead
bacteria
respons
respiratori
infect
patient
recruit
studi
similar
work
kang
et
al
report
common
respiratori
bacteri
infect
caus
h
influenza
pneumonia
respiratori
syncyti
viru
similar
studi
also
demonstr
pneumonia
fig
boxplot
white
blood
cell
count
wbc
neutrophil
level
patient
found
infect
singl
multipl
bacteri
pathogen
h
influenza
p
aeruginosa
e
coli
aureu
maltophilia
mrsa
use
ebclamp
also
commerci
lamp
devic
symbol
group
number
patient
classifi
group
wbcwhite
blood
cell
n
percentag
neutrophil
routin
blood
test
shown
tabl
support
inform
h
influenza
pneumonia
c
pneumonia
often
predomin
outpati
inpati
respiratori
diseas
et
al
h
influenza
bacterium
first
isol
pfeiffer
influenza
pandem
gramneg
opportunist
bacterium
appear
coccobacilli
work
addit
h
influenza
also
found
aureu
mrsa
p
aeruginosa
e
coli
also
exhal
infect
patient
result
work
studi
indic
pathogen
could
emit
transmit
exhal
breath
thu
ad
addit
risk
infecti
diseas
transmiss
studi
airborn
andor
droplet
transmiss
identifi
major
rout
spread
human
anim
bacteria
e
coli
aureu
anthrax
k
pneumonia
p
aeruginosa
ijaz
zargar
wright
rubino
sattar
knibb
et
al
li
et
al
pyankov
et
al
use
pathogen
size
distinguish
droplet
airborn
smaller
transmiss
exhal
particl
previou
work
found
bacteri
concentr
cfum
detect
exhal
breath
includ
viabl
dead
cell
variou
type
among
bacteria
sphingomona
paucimobili
kocuria
variant
found
domin
ebc
sampl
collect
healthi
subject
use
vitek
system
work
sem
imag
reveal
bacteria
exhal
breath
detect
size
rang
smaller
particl
accordingli
pose
greater
risk
airborn
transmiss
exhal
especi
pathogen
mrsa
anoth
work
shown
human
could
emit
million
bacteri
particl
per
min
among
exhal
breath
fluoresc
bioaerosol
concentr
level
particl
peak
size
xu
wu
yao
besid
human
activ
could
also
resuspend
huge
amount
bioaerosol
particl
pathogen
exhal
ambient
air
would
suspend
air
long
period
time
accordingli
travel
greater
distanc
increas
respiratori
infect
transmiss
risk
wuri
lawn
booth
sonnenberg
hayward
emiss
either
natur
infect
individu
repres
import
infect
risk
certain
condit
howev
often
even
develop
countri
diagnosi
infect
type
health
profession
empir
reli
white
blood
cell
wbc
neutrophil
level
routin
blood
test
accompani
clinic
symptom
headach
cough
arthralgia
principl
practic
lack
scientif
evid
result
suggest
use
higher
wbc
valu
eg
wbc
normal
indic
bacteri
infect
might
accur
term
identifi
respiratori
infect
type
bacteria
virus
practic
scenario
physiolog
condit
vari
significantli
individu
could
differ
immun
statu
age
medic
histori
genet
infect
multipl
agent
bacteria
virus
rather
difficult
judg
infect
type
pure
routin
blood
examin
also
clinic
symptom
problem
go
mani
year
without
activ
solut
develop
lack
solut
often
lead
abus
use
antibiot
develop
ebclamp
togeth
throat
swab
found
use
rapid
identifi
bacteri
pathogen
applic
develop
method
alreadi
use
identifi
bacteri
pathogen
two
medic
case
involv
two
children
hospit
icu
child
age
diagnos
sever
pneumonia
hospit
icu
inner
mongolia
hospit
success
detect
legionella
pneumophila
throat
swab
use
method
describ
anoth
hospit
babi
pediatr
intens
care
unit
picu
beij
mrsa
aureu
pneumophila
detect
throat
swab
sampl
take
min
lamp
detect
cultur
method
need
least
day
detect
result
could
help
doctor
make
appropri
decis
medic
treatment
particularli
certain
agent
l
pneumophila
mrsa
two
type
pathogen
medic
avail
might
work
better
eg
mrsa
resist
mani
antibiot
time
accur
diagnosi
respiratori
pathogen
could
play
vital
role
help
patient
recov
ill
overal
work
provid
feasibl
protocol
rapid
detect
respiratori
pathogen
especi
use
underdevelop
area
ebclamp
protocol
valid
compar
standard
method
qpcr
result
demonstr
ebclamp
method
might
sensit
qpcr
possibl
due
inhibit
problem
qpcr
sampl
matrix
sampl
often
need
severalfold
dilut
elimin
impact
amplif
addit
lamp
method
use
two
addit
loop
primer
detect
pathogen
acceler
lamp
reaction
also
improv
kinet
sensit
lamp
reaction
notomi
mori
tomita
kanda
addit
measur
turbid
use
instrument
detect
result
lamp
method
also
made
judg
visual
nake
eye
due
product
high
concentr
amplif
product
exampl
white
magnesium
pyrophosph
precipit
gener
strand
displac
autocycl
reaction
could
easili
seen
bottom
microfug
tube
ad
fluoresc
dye
sybr
green
reaction
tube
could
lead
eventu
color
chang
exampl
reaction
tube
appear
fluoresc
color
ultraviolet
radiat
sampl
posit
specif
pathogen
neg
control
sampl
without
pathogen
color
wo
nt
chang
way
provid
easi
way
identifi
reaction
result
turbid
instrument
avail
ebc
sampl
rel
simpl
compar
throat
swab
often
need
sampl
pretreat
pcr
lamp
analysi
besid
lamp
method
also
develop
new
dna
extract
solut
involv
lamp
method
onsit
bacteri
screen
requir
reagent
effici
obtain
bacteri
dna
within
min
detail
method
file
patent
report
elsewher
current
studi
focu
breathborn
virus
studi
one
fewer
studi
report
releas
bacteri
pathogen
exhal
gener
pathogen
exhal
becom
dri
immedi
thu
possibl
transmit
place
data
real
clinic
set
import
impact
healthcar
provid
addit
result
contribut
understand
hospit
infect
also
breathborn
pathogen
transmiss
literatur
overal
develop
ebclamp
protocol
great
potenti
readili
made
avail
remot
less
develop
region
resourc
limit
prohibit
integr
commerci
ebc
collect
devic
pku
bioscreen
lamp
method
develop
rapid
effici
protocol
screen
respiratori
bacteri
pathogen
result
lamp
assay
shown
gener
consist
qpcr
assay
sampl
sensit
lamp
found
slightli
higher
pcr
amplif
use
protocol
shown
mani
pathogen
h
influenza
p
aeruginosa
e
coli
aureu
mrsa
could
emit
infect
patient
via
exhal
breath
similar
studi
work
also
demonstr
h
influenza
lead
pathogen
respons
common
respiratori
infect
howev
viabil
infect
airborn
exposur
need
investig
overal
protocol
rapid
effect
noninvas
method
diagnosi
infect
pathogen
success
identifi
bacteri
pathogen
two
hospit
child
icu
futur
protocol
made
portabl
avail
bedsid
use
nonetheless
result
use
protocol
could
neg
impact
number
patient
involv
also
distribut
pattern
patient
gender
age
medic
histori
addit
regardless
method
test
use
throat
swab
sampl
result
high
posit
rate
select
pathogen
compar
ebc
sampl
might
due
differ
sourc
pathogen
differ
type
respiratori
infect
lower
upper
respiratori
tract
infect
futur
work
ebclamp
protocol
also
test
screen
breathborn
virus
addit
increas
sampl
size
patient
improv
besid
transport
transmiss
exhal
pathogen
could
also
explor
use
aerosol
monitor
togeth
molecular
method
biosensor
